StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
SKIN-R.BK$1.00+2.04%
Fair $1.00+0.0%

SKIN-R.BK

Skin Laboratory Public Company Limited

Consumer Defensive / Household & Personal ProductsThailand

$1.00

+0.02 (+2.04%)

Fairly Valued+0.0%Fair Value $1.00Fund rank 33/100 · Data gapFallback financials|
SA 44/C
F-Score: 4/9
Declining RevenueLow Profitability

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 31% · confianza 25%

FCF escenarios

weak_data · normalized FCF $12.5M · quality 67.0/100

Data gap 33/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 48/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

44/100

C

Piotroski

4/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 2unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified. Revenue has declined for 3 consecutive years ROE is 4.3%, below the 5% threshold
Thesis & Journal · SKIN-R.BKLocal privado en este navegador · Skin Laboratory Public Company Limited
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$144M

P/E

25.7x

↑

EV/EBITDA

5.6x

↓

ROE

4.3%

↓

Gross Margin

72.0%

↑

Debt/Equity

0.01

↓
52-Week Range$1
$1$4

TradingView lightweight chart

SKIN-R.BK price, volumen y niveles de valoración

Último $1.000Periodo -72.4%
Fair value: $1.000

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

-14.4%

FCF CAGR

+38.0%

FCF margin

7.0%

FCF / Net income

2.85x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $176.7M · net income $4.4M · FCF $12.5M

2022-FY → 2025-FY

Gross margin

72.0%-3.0% pts

Operating margin

3.3%-1.5% pts

Net margin

2.5%-1.3% pts

FCF margin

7.0%+5.4% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$176.7M$176.7M$229.1M$271.8M$282.1M
Net Income$4.4M$4.4M$10.7M$16.7M$10.7M
EBITDA$7.5M$7.5M$16.1M$22.3M$14.8M
EPS0.040.040.070.120.07
Gross Margin72.0%72.0%74.9%76.7%75.0%
Operating Margin3.3%3.3%5.9%7.5%4.7%
Net Margin2.5%2.5%4.7%6.1%3.8%
Balance Sheet
Debt/Equity0.010.010.040.060.05
Current Ratio6.416.41———
Cash Flow
Free Cash Flow$12.5M$12.5M$4.6M$26.4M$4.7M
Returns
ROE4.3%4.3%17.3%23.2%14.9%
Valuation
P/E25.7125.71———
EV/EBITDA5.575.57———
P/B1.111.11———
Growth & Yield
Revenue Growth-22.9%-22.9%-15.7%-3.7%—
EPS Growth-47.5%-47.5%-36.1%56.1%—

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%

3Y implied EPS CAGR

31.6%

muy exigente

EPS terminal req.

$0.09

Spread vs growth

-79.1%

5Y implied EPS CAGR

22.5%

exigente

EPS terminal req.

$0.11

Spread vs growth

-70.0%

10Y implied EPS CAGR

16.1%

exigente

EPS terminal req.

$0.17

Spread vs growth

-63.6%

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · available periodreconcilia total -72.4%

Total return

-72.4%

Start / end P/E

48.9x → 25.7x

EPS bridge

0.07 → 0.04

Residual

+22.5%

EPS growth-47.5%
Multiple rerating-47.4%
Dividend+0.0%
Residual / FX / buybacks / cross-term+22.5%

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.